Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Debt Ratio (2016 - 2019)

Fate Therapeutics (FATE) has disclosed Debt Ratio for 8 consecutive years, with 0.04 as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Debt Ratio fell 39.4% year-over-year to 0.04, compared with a TTM value of 0.04 through Sep 2019, down 39.4%, and an annual FY2018 reading of 0.07, down 50.32% over the prior year.
  • Debt Ratio was 0.04 for Q3 2019 at Fate Therapeutics, down from 0.07 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.44 in Q1 2015 and bottomed at 0.04 in Q3 2019.
  • Average Debt Ratio over 5 years is 0.18, with a median of 0.16 recorded in 2018.
  • The sharpest move saw Debt Ratio skyrocketed 1670.23% in 2015, then tumbled 69.69% in 2017.
  • Year by year, Debt Ratio stood at 0.27 in 2015, then crashed by 58.42% to 0.11 in 2016, then grew by 25.07% to 0.14 in 2017, then plummeted by 50.32% to 0.07 in 2018, then crashed by 41.39% to 0.04 in 2019.
  • Business Quant data shows Debt Ratio for FATE at 0.04 in Q3 2019, 0.07 in Q2 2019, and 0.07 in Q1 2019.